Sranan Gold Announces Further High-Potential Exploration Targets at the Tapanahony Gold Project in Suriname
Each of the target areas (see Figure 1) has been identified by a combination Lidar survey, geophysics, geological interpretation, exploration data from previous operators, field work and, most importantly, local mining activity. The areas currently identified are referred to as Randy's Pit, Randy's Extension, Randy West, Poeketi Pit, West Poeketi, South Intrusion, Enard North and Enard South.
Dr. Dennis LaPoint, EVP Exploration and Corporate Development of Sranan Gold, commented: 'Our expanded 10,000-metre drill program marks a major step forward in systematically unlocking the potential of our district-scale property. With an adaptive approach guided by rapid assay turnaround and new structural and lithologic data and analysis, we're confident this program will significantly advance our understanding of the project's scale and resource potential.'
[ This image cannot be displayed. Please visit the source: https://images.newsfilecorp.com/files/10997/255592_adc68cf7c43238a4_001.jpg ]
Figure 1: Priority exploration targets at the Tapanahony Gold Project, Suriname.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10997/255592_adc68cf7c43238a4_001full.jpg
Randy's Pit is the first priority for drilling, which is based on historical drilling by Iamgold and later mining by local miners at Randy's Pit.
Newly identified zone Randy's Extension is the southeast continuation of the Randy trend, where a potential granite contact — similar in style to mineralization at the Oko West gold discovery in northwest Guyana — may exist. This 1.6-kilometre trend will be explored while the excavator is in the area for drilling at Randy's Pit, leveraging mobilization efficiencies. The goal is to confirm the continuity of the Randy trend beyond its known limits. Drilling will follow.
Newly identified zone Randy West targets a parallel zone immediately west of Randy trend. Two ridges, each roughly two kilometres in length, display evidence of historical pits and alluvial workings, suggesting a nearby intrusive source. As the excavator works at Randy's Pit to support drilling, trenching will commence on these ridges to test for mineralization and to define drill targets along this parallel trend.
The Poeketi Pit target is the site of a recent gold rush starting in 2020. Active mining is characterized by a high-grade, fault-filled vein system. Drilling is planned on the 350-metre-long Poeketi open pit, which hosts five underground shafts, and the 150-metre-long New Pit. In between is a 260-metre ridge due to the fault-filled vein which will be tested first by trenching.
A trenching program is planned at West Poeketi on its southern region to delineate mineralized structures to select drill sites. A northeast striking soil sampling campaign toward the concession's northwest boundary will later be used to extend known mineralized trends and highlight areas for further exploration.
The newly identified South Intrusion target lies to the southeast of the Randy trend, where an arc of shallow auger anomalies closely follows the greenstone-intrusive contact, like Oko and Oko West. Historically, Iamgold panning anomalies in this area indicated a potential source of mineralization. This target region spans five to ten kilometres in strike length.
New identified Enard North and Enard South benefit from detailed Lidar coverage and extensive alluvial mining, both of which highlight the potential of the Enard concession. At Enard South, two large-scale folds were revealed by Lidar, supported by active artisanal mining. The fold axes correspond to catchment anomalies identified in panning by Iamgold. Focused mapping, sampling and auger drilling will be the primary methods to develop targets in this fold-hosted setting that has similarities to the Merian and Rosebel mines.
Qualified Person
Dr. Dennis J. LaPoint, Ph.D., P.Geo. a 'qualified person' as defined under National Instrument 43‐101, has reviewed and approved the scientific and technical information in this release. Dr. LaPoint is not independent of Sranan Gold, as he is the Company's EVP Exploration and Corporate Development.
About Sranan Gold
Sranan Gold Corp. is engaged in the business of mineral exploration and the acquisition of mineral property assets in Suriname. The highly prospective Tapanahony Project is located in the heart of Suriname's modern-day gold rush. Tapanahony covers 29,000 hectares in one of the oldest and largest small-scale mining areas in Suriname. There is significant production from saprolite by local miners along a 4.5-kilometre trend, where several areas of mining have been opened.
Sranan Gold is also exploring its Aida Property consisting of five mineral claims covering an area of 2,335.42 hectares on the Shuswap Highland within the Kamloops Mining Division.
For more information, visit sranangold.com.
Information contact
Oscar Louzada, CEO
+31 6 25438975
THE CANADIAN SECURITIES EXCHANGE HAS NOT APPROVED NOR DISAPPROVED THE CONTENT OF THIS PRESS RELEASE.
Forward-Looking Statements
Certain statements in this release constitute 'forward-looking statements' or 'forward-looking information' within the meaning of applicable securities laws including, without limitation, the timing, nature, scope and details regarding the Company's exploration plans and results at its projects. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, its projects, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as 'may', 'would', 'could', 'will', 'intend', 'expect', 'believe', 'plan', 'anticipate', 'estimate', 'scheduled', 'forecast', 'predict' and other similar terminology, or state that certain actions, events or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. These statements reflect the company's current expectations regarding future events, performance and results and speak only as of the date of this release.
Forward-looking statements and information contained herein are based on certain factors and assumptions regarding, among other things, the estimation of mineral resources and reserves, the realization of resource and reserve estimates, metal prices, taxation, the estimation, timing and amount of future exploration and development, capital and operating costs, the availability of financing, the receipt of regulatory approvals, environmental risks, title disputes and other matters. While the Company considers its assumptions to be reasonable as of the date hereof, forward-looking statements and information are not guarantees of future performance and readers should not place undue importance on such statements as actual events and results may differ materially from those described herein. The Company does not undertake to update any forward-looking statements or information except as may be required by applicable securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255592
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Eureka Lithium Corp. Completes Debt Settlements
Vancouver, British Columbia--(Newsfile Corp. - July 29, 2025) - Eureka Lithium Corp. (CSE: ERKA) (OTCQB: UREKF) (FSE: S58) ("Eureka Lithium" or "Eureka" or the "Company") announces that, further to its news release dated July 14, 2025, it has issued an aggregate of 1,018,945 common shares (each, a "Share") in the capital of the Company at a deemed price of C$0.1425 per Share to settle debts owed and outstanding loans to various creditors for a total amount of $145,200 (the "Debt Settlements"). In connection with the Debt Settlements, Dave Bowen, the CEO and a director of the Company, received 110,526 Shares to settle the C$15,750 he was owed. The issuance of Mr. Bowen's Shares is considered a "related party transaction" pursuant to Multilateral Instrument 61-101- Protection of Minority Holders in Special Transactions ("MI 61-101") and is exempt from the formal valuation and minority shareholder approval requirements of MI61-101 by virtue of the exemptions contained in Sections 5.5(b) and 5.7(1)(b) of MI 61-101. The Shares issued in connection with the Debt Settlements are subject to a statutory hold period of four months following the date of issuance, in accordance with applicable securities legislation and Canadian Securities Exchange ("CSE") policies. About Eureka Lithium Corp. Eureka Lithium is the largest lithium-focused landowner in the northern third of Quebec, known as the Nunavik region, with 100% ownership of three projects comprising 2,108 sq. km in the emerging Raglan West, Raglan South and New Leaf Lithium Camps. These claims were acquired from legendary prospector Shawn Ryan and are located in a region that hosts two operating nickel mines with deep-sea port access. For more information, please contact: David BowenChief Executive OfficerEmail: info@ Cautionary Statement Certain statements contained in this news release, including statements which may contain words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", or similar expressions, and statements related to matters which are not historical facts, such as statements regarding the closing of the debt settlement and the hold period of the Shares, are forward-looking information within the meaning of applicable securities laws. Such forward-looking statements reflect management's expectations and are based on certain factors and assumptions and involve known and unknown risks and uncertainties which may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by such forward-looking statements. These factors should be considered carefully, and readers should not place undue reliance on the Company's forward-looking statements. The Company believes that the expectations reflected in the forward-looking statements contained in this news release are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company undertakes no obligation to release publicly any future revisions to forward-looking statements to reflect events or circumstances after the date of this news or to reflect the occurrence of unanticipated events, except as expressly required by law. The Canadian Securities Exchange (CSE) has not reviewed, approved, or disapproved the contents of this press release. Not for distribution to United States newswire services or for release publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States To view the source version of this press release, please visit


Business Upturn
32 minutes ago
- Business Upturn
Treatment.com AI Engages Market Maker
Vancouver, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — AI Inc. (the 'Company' or 'Treatment') (CSE: TRUE; OTC: TREIF; 939: FRA) has engaged the services of Independent Trading Group ('ITG') pursuant to an agreement dated and starting on July 29, 2025 (the 'Agreement') to provide market-making services in accordance with Canadian Securities Exchange ('CSE') policies. ITG will trade shares of the Company on the CSE and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares. Under the terms of the Agreement, ITG will receive compensation of CAD $5,500 per month, payable monthly in advance. The Agreement is for an initial term of one month and will renew for additional one-month terms unless terminated by either party with 30 days' notice. There is no performance factors contained in the Agreement and ITG will not receive shares or options as compensation. ITG and the Company are unrelated and unaffiliated entities. Independent Trading Group (ITG) Inc. is a Toronto based CIRO dealer-member that specializes in market making, liquidity provision, agency execution, ultra-low latency connectivity, and bespoke algorithmic trading solutions. Established in 1992, with a focus on market structure, execution and trading, ITG has leveraged its own proprietary technology to deliver high quality liquidity provision and execution services to a broad array of public issuers and institutional investors. About AI Inc. AI is a company utilizing AI and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than ~10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and enables greater consistency in quality of patient support. Treatment's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment's products and services: or email: [email protected] m FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO [email protected] For media inquiries, contact: [email protected] Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statements This news release contains forward-looking statements relating to the future operations of Treatment and other statements that are not historical facts. Forward-looking statements are often identified by terms such as 'will', 'may', 'should', 'anticipate', 'expects' and similar expressions. All statements other than statements of historical fact, included in this release, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash


Hamilton Spectator
2 hours ago
- Hamilton Spectator
Treatment.com AI Engages Market Maker
Vancouver, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — AI Inc. (the 'Company' or 'Treatment') (CSE: TRUE; OTC: TREIF; 939: FRA) has engaged the services of Independent Trading Group ('ITG') pursuant to an agreement dated and starting on July 29, 2025 (the 'Agreement') to provide market-making services in accordance with Canadian Securities Exchange ('CSE') policies. ITG will trade shares of the Company on the CSE and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares. Under the terms of the Agreement, ITG will receive compensation of CAD $5,500 per month, payable monthly in advance. The Agreement is for an initial term of one month and will renew for additional one-month terms unless terminated by either party with 30 days' notice. There is no performance factors contained in the Agreement and ITG will not receive shares or options as compensation. ITG and the Company are unrelated and unaffiliated entities. Independent Trading Group (ITG) Inc. is a Toronto based CIRO dealer-member that specializes in market making, liquidity provision, agency execution, ultra-low latency connectivity, and bespoke algorithmic trading solutions. Established in 1992, with a focus on market structure, execution and trading, ITG has leveraged its own proprietary technology to deliver high quality liquidity provision and execution services to a broad array of public issuers and institutional investors. About AI Inc. AI is a company utilizing AI and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than ~10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and enables greater consistency in quality of patient support. Treatment's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment's products and services: or email: info@ m FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO ehamza@ For media inquiries, contact: media@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Cautionary Statements This news release contains forward-looking statements relating to the future operations of Treatment and other statements that are not historical facts. Forward-looking statements are often identified by terms such as 'will', 'may', 'should', 'anticipate', 'expects' and similar expressions. All statements other than statements of historical fact, included in this release, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.